Compare Godaddy Inc (GDDY) vs Hims and Hers Health Inc (HIMS) Price & Performance

GoDaddy (GDDY) trades at $94.12, up 3.31% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong earnings beats in recent quarters, with Q2 2026 results due July 30, 2026. Fundamentals show robust profitability with a 17.32% net margin and 63.77% gross margin, though revenue growth is moderating. Analyst consensus is bullish with a $123 price target, but legal investigations pose sentiment risks.

Outlook remains positive given earnings momentum and high analyst buy ratings, but investors face near-term volatility from legal overhangs and elevated valuation multiples. The stock offers upside to consensus targets if execution continues, yet legal and competitive pressures require monitoring for sustained growth.

Hims & Hers Health trades at $34.78, down 1.05% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. Fundamentally, the company reported $2.35B revenue in 2025 but faces profitability challenges with a negative net income margin of -0.56% and elevated valuation ratios including a P/E of 57.14. Recent news highlights expansion in weight-loss therapies and international markets, with Q2 2026 earnings due August 10, 2026.

The outlook remains cautiously optimistic with analyst consensus at Buy (35%) and a $33.57 price target near current levels. Key opportunities include GLP-1 therapy growth and subscriber additions, while risks involve profitability pressures, competitive threats, and reliance on regulatory approvals. The stock's performance hinges on execution in high-margin segments and cost management amid expansion.